Collaborations, Competitor News, Oncology

ConcertAI’s TeraRecon partners with Optellum to integrate AI-powered early lung cancer diagnosis and precision treatment planning

Posted on

CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning. Through this partnership, the Optellum Virtual Nodule Clinic solution…

Academic, Collaborations, Data Partnership, Partner and Collaborator News

All of Us Research Program Establishes New Center for Linkage and Acquisition of Data

Posted on

October 12, 2023 $30 million award will expand program’s data and research capabilities  The National Institutes of Health’s All of Us Research Program has awarded $30 million to the University of Colorado Anschutz Medical Campus and its partners to establish the Center for Linkage and Acquisition of Data (CLAD). The center will…

Blogs/Publications, Competitor News, Marketing

Expanding Opportunities to Leverage Real-World Data

Posted on

Non-profit patient organizations and medical specialty societies provide valuable real-world data that can facilitate academic research, educate through publications, and provide patient insights. This data can be leveraged to provide insights on the natural history of disease, study feasibility, epidemiological information on patient populations, and patient treatment patterns. Non-profits and…

Competitor News, Government/Regulatory

U.S. Food and Drug Administration (FDA) Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo® (selpercatinib) for Certain Patients with Solid Tumors

Posted on

Foundation Medicine’s tissue-based comprehensive genomic profiling test is now FDA approved to identify patients with solid tumors with RET gene fusions who may benefit from treatment with Retevmo October 09, 2023 07:05 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine Inc. today announced that it has received approval from the U.S….

Blogs/Publications, Competitor News, Marketing

Why linking clinical trials to real-world data is the critical next step for medical device development

Posted on

Connecting medical device clinical trials to real-world data (RWD) helps demonstrate efficacy, safety and cost-effectiveness. Mehdi NajafZadeh, Medidata Medical device and diagnostics manufacturers need to build data linkage into their clinical trial planning today to remove silos and mobilize efficient use of data sources for better clinical evidence generation in the years…

AI, Competitor News, Product Updates

Atropos Health Launches New Geneva OS and ChatRWD User Application for Rapid Real World Evidence With Generative AI

Posted on

October 05, 2023 09:30 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–Atropos Health, leader in evidence generation for healthcare, today announced the launch of the Geneva OS™(Generative Evidence Acceleration Operating System) and the ChatRWD™ (Real World Data) application, the first Generative AI application incorporating direct Chat-to-Database capability, to help healthcare…

Competitor News, Government/Regulatory

Komodo Health Awarded CMS Innovator’s License, Enabling Integration of Critical Payer Data To Enhance Customers’ Understanding of Patient Experience and Needs

Posted on

As the company continues to invest in the quality of data in its Healthcare Map, the coveted Innovator’s License from the Centers for Medicare & Medicaid Services (CMS) will unlock an unparalleled depth and breadth of connected patient journey insights for Healthcare and Life Sciences October 05, 2023 08:00 AM…